These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27816294)

  • 1. Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review.
    Chen X; Jiang X; Yang M; Bennett C; González U; Lin X; Hua X; Xue S; Zhang M
    J Am Acad Dermatol; 2017 Feb; 76(2):368-374. PubMed ID: 27816294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic antifungal therapy for tinea capitis in children.
    Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antifungal therapy for tinea capitis in children.
    González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
    Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials.
    Elewski BE; Cáceres HW; DeLeon L; El Shimy S; Hunter JA; Korotkiy N; Rachesky IJ; Sanchez-Bal V; Todd G; Wraith L; Cai B; Tavakkol A; Bakshi R; Nyirady J; Friedlander SF
    J Am Acad Dermatol; 2008 Jul; 59(1):41-54. PubMed ID: 18378354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tinea capitis in children: a systematic review of management.
    Gupta AK; Mays RR; Versteeg SG; Piraccini BM; Shear NH; Piguet V; Tosti A; Friedlander SF
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2264-2274. PubMed ID: 29797669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatments for tinea capitis.
    Chan YC; Friedlander SF
    Curr Opin Infect Dis; 2004 Apr; 17(2):97-103. PubMed ID: 15021047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcomes for tinea capitis in a skin of color population.
    Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
    J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis.
    Gupta AK; Drummond-Main C
    Pediatr Dermatol; 2013; 30(1):1-6. PubMed ID: 22994156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea Capitis: An Updated Review.
    Leung AKC; Hon KL; Leong KF; Barankin B; Lam JM
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):58-68. PubMed ID: 31906842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral griseofulvin remains the treatment of choice for tinea capitis in children.
    Bennett ML; Fleischer AB; Loveless JW; Feldman SR
    Pediatr Dermatol; 2000; 17(4):304-9. PubMed ID: 10990583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinea capitis: an overview with emphasis on management.
    Gupta AK; Hofstader SL; Adam P; Summerbell RC
    Pediatr Dermatol; 1999; 16(3):171-89. PubMed ID: 10383772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
    Friedlander SF
    Pediatr Infect Dis J; 1999 Feb; 18(2):205-10. PubMed ID: 10048703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
    Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D; Gaughan JP; Aronoff SC
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of tinea capitis in Israel: A comparative study.
    Shemer A; Gupta AK; Galili E; Daniel R; Kassem R; Farhi R; Grunwald H; Bamimore MA
    Pediatr Dermatol; 2021 Jul; 38(4):806-811. PubMed ID: 33998709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Griseofulvin and terbinafine in the treatment of tinea capitis in children.
    Rademaker M; Havill S
    N Z Med J; 1998 Feb; 111(1060):55-7. PubMed ID: 9539918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.